Upgrade to SI Premium - Free Trial

Form 3 InflaRx N.V. For: Mar 18 Filed by: Taapken Thomas

March 18, 2026 8:07 AM
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person *
Taapken Thomas
(Last) (First) (Middle)
C/O INFLARX N.V.
WINZERLAER STREET 2
(Street)
JENA 07745
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026 		3. Issuer Name and Ticker or Trading Symbol
InflaRx N.V. [ IFRX ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
 5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares 3,500
D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) (1) 09/17/2030 Ordinary Shares 150,000 1.86 I By tomtaa GmbH (2)
Stock Option (Right to Buy) (3) 01/04/2031 Ordinary Shares 50,000 1.86 I By tomtaa GmbH (2)
Stock Option (Right to Buy) (4) 07/01/2031 Ordinary Shares 32,002 1.86 I By tomtaa GmbH (2)
Stock Option (Right to Buy) (5) 01/11/2032 Ordinary Shares 110,000 1.86 I By tomtaa GmbH (2)
Stock Option (Right to Buy) (6) 11/21/2032 Ordinary Shares 55,000 2.44 I By tomtaa GmbH (2)
Stock Option (Right to Buy) (7) 01/24/2033 Ordinary Shares 110,000 2.37 I By tomtaa GmbH (2)
Stock Option (Right to Buy) (8) 01/05/2034 Ordinary Shares 210,000 1.79 I By tomtaa GmbH (2)
Stock Option (Right to Buy) (9) 01/03/2035 Ordinary Shares 240,000 2.41 I By tomtaa GmbH (2)
Stock Option (Right to Buy) (10) 01/06/2036 Ordinary Shares 240,000 1.17 I By tomtaa GmbH (2)
Performance Stock Option (Right to Buy) (11) 01/06/2036 Ordinary Shares 72,000 1.17 I By tomtaa GmbH (2)
Explanation of Responses:
1. This option was granted on September 18, 2020 and is fully vested and exercisable as of the date hereof.
2. The reported securities are directly held by tomtaa GmbH, a company wholly owned by the Reporting Person for which the Reporting Person acts as sole managing director. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.
3. This option was granted on January 4, 2021 and is fully vested and exercisable as of the date hereof.
4. This option was granted on July 2, 2021 and is fully vested and exercisable as of the date hereof.
5. This option was granted on January 12, 2022 and is fully vested and exercisable as of the date hereof.
6. This option was granted on November 21, 2022 and is fully vested and exercisable as of the date hereof.
7. This option was granted on January 24, 2023 and is fully vested and exercisable as of the date hereof.
8. This option was granted on January 5, 2024 and is fully vested and exercisable as of the date hereof.
9. This option was granted on January 3, 2025 and is fully vested and exercisable as of the date hereof.
10. This option was granted on January 6, 2026 and will vest and become exercisable in four equal installments of 60,000 shares on each quarterly anniversary of such grant date, subject to continued service through such dates.
11. This option shall vest depending upon achievement of the following performance criteria: (i) 50% shall vest if a certain financing event takes place before the fourth quarter of 2026 and (ii) 50% shall vest if the average Ordinary Share price for quarter four of 2026 exceeds $1.50.
Remarks:
Exhibit List - Exhibit 24.1 Power of Attorney
/s/ Christian Schmid, Attorney-in-Fact 03/18/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

ATTACHMENTS / EXHIBITS

POWER OF ATTORNEY

Categories

SEC Filings